| 000 | 02516 a2200673 4500 | ||
|---|---|---|---|
| 005 | 20250518074758.0 | ||
| 264 | 0 | _c20200917 | |
| 008 | 202009s 0 0 eng d | ||
| 022 | _a1745-6215 | ||
| 024 | 7 |
_a10.1186/s13063-019-3953-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNochaiwong, Surapon | |
| 245 | 0 | 0 |
_aComparative Effectiveness of Local Application of Chlorhexidine Gluconate, Mupirocin Ointment, and Normal Saline for the Prevention of Peritoneal Dialysis-related Infections (COSMO-PD Trial): a multicenter randomized, double-blind, controlled protocol. _h[electronic resource] |
| 260 |
_bTrials _cDec 2019 |
||
| 300 |
_a754 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial Protocol; Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Topical |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAnti-Infective Agents, Local _xadministration & dosage |
| 650 | 0 | 4 |
_aCatheter-Related Infections _xdiagnosis |
| 650 | 0 | 4 |
_aCatheters, Indwelling _xadverse effects |
| 650 | 0 | 4 |
_aChlorhexidine _xadministration & dosage |
| 650 | 0 | 4 | _aClinical Trials, Phase IV as Topic |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Costs |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xtherapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMulticenter Studies as Topic |
| 650 | 0 | 4 |
_aMupirocin _xadministration & dosage |
| 650 | 0 | 4 |
_aNasal Mucosa _xmicrobiology |
| 650 | 0 | 4 |
_aPeritoneal Dialysis _xadverse effects |
| 650 | 0 | 4 |
_aPeritonitis _xdiagnosis |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aSaline Solution _xadministration & dosage |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xdiagnosis |
| 650 | 0 | 4 |
_aStaphylococcus aureus _xisolation & purification |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aRuengorn, Chidchanok | |
| 700 | 1 | _aNoppakun, Kajohnsak | |
| 700 | 1 | _aPanyathong, Setthapon | |
| 700 | 1 | _aDandecha, Phongsak | |
| 700 | 1 | _aSood, Manish M | |
| 700 | 1 | _aSaenjum, Chalermpong | |
| 700 | 1 | _aAwiphan, Ratanaporn | |
| 700 | 1 | _aSirilun, Sasithorn | |
| 700 | 1 | _aMongkhon, Pajaree | |
| 700 | 1 | _aChongruksut, Wilaiwan | |
| 700 | 1 | _aThavorn, Kednapa | |
| 773 | 0 |
_tTrials _gvol. 20 _gno. 1 _gp. 754 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s13063-019-3953-8 _zAvailable from publisher's website |
| 999 |
_c30439903 _d30439903 |
||